View of Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors

Return to Issue Details Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors Download Download PDF